Stockreport

Roivant Sciences Ltd (ROIV) Q2 2024 Earnings Call Highlights: Strong Cash Position and ... [Yahoo! Finance]

Roivant Sciences Ltd.  (ROIV) 
PDF R&D Expense: $143 million; adjusted non-GAAP R&D expense of $132 million. G&A Expense: $203 million; adjusted non-GAAP G&A expense of $142 million. Loss from Contin [Read more]